Rio-Vilarino A, Cenigaonandia-Campillo A, Garcia-Bautista A, Mateos-Gomez PA, et al. Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. Br J Cancer 2024 Mar 11. doi: 10.1038/s41416-024-02649.
PMID: 38467828